Research Malaria Prevention Licensing Opportunity: mAbs That Target SporozoitesGlobal Biodefense StaffMarch 17, 2025
Research New Virus Characterization Center Will Conduct Sweeping Study of Human VirusesGlobal Biodefense StaffJanuary 23, 2025
Medical Countermeasures Lassa Fever Vaccine Study Supports Advancement to Phase I TrialGlobal Biodefense StaffAugust 14, 2024
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline Medical Countermeasures January 10, 2023 …
NIH Grant Will Expand National Swine Resource and Research Center Medical Countermeasures October 25, 2022 …
Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs Medical Countermeasures September 9, 2022 …
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination Medical Countermeasures July 16, 2022 …
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents CBRNE April 11, 2022 …
Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis CBRNE February 27, 2022 …
Particles Carrying Viruses Likely Travel Farther Than Previously Thought Pathogens February 17, 2022 …
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus Biosecurity February 6, 2022 …